Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

Share Price is delayed by 15 minutes
Get Live Data
1,015.00    15.00 (1.50%)
Bid:
1,010.00
Ask:
1,015.00
Spread: 5.00 (0.495%)
Market Cap: £323.05m
IBT Live PriceLast checked at - London Stock Exchange

Intraday Int.biotech. Share Chart

Change of Auditors

9 Dec 2025 11:23

RNS Number : 8564K
Intl. Biotechnology Trust PLC
09 December 2025
Β 

9 December 2025

Β 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Β 

(the "Company")

Β 

Change of Auditors

Β 

Β 

Following a formal and competitive tender process overseen by the Audit Committee of the Company, the Board has proposed the appointment of Johnston Carmichael LLP as the Company's auditors for the financial year ending 31 August 2026. A resolution to appoint Johnston Carmichael LLP will be put to shareholders at the Company's next Annual General Meeting ("AGM") to be held on 12 December 2025. PricewaterhouseCoopers LLP ("PwC") has served as the Company's auditors since 2007 and was reappointed following a tender in 2016. PwC will cease to hold office as the Company's auditors at the conclusion of the 2025 AGM.

Β 

In reaching the decision to propose the appointment of Johnston Carmichael LLP, the Board was mindful of the requirement to rotate the senior statutory auditor following the audit of the 2025 financial statements, as well as the need to conduct another audit tender by 2027 due to the 20-year maximum tenure for audit firms.

Β 

As required by section 519 of the Companies Act 2006, PwC has deposited a statement with the Company confirming that there are no matters connected with its ceasing to hold office as auditors that need to be brought to the attention of members or creditors of the Company.

Β 

In accordance with UK Listing Rule 6.4.1, a copy of the section 519 statement will be uploaded to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Β 

The Board would like to thank PwC for its professional service to the Company throughout its tenure in office.

Β 

Β 

Β 

Enquiries:

Β 

Schroder Investment Management Limited

Natalia de Sousa

Tel: 0207 658 6000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
APPUPGGPPUPAGGB
Date   Source Headline
22nd Jun 20263:35 pmRNS-RPortfolio company Apogee to be acquired by AbbVie
22nd Jun 202611:27 amRNSNet Asset Value(s)
19th Jun 202611:16 amRNSNet Asset Value(s)
18th Jun 202611:00 amRNSNet Asset Value(s)
17th Jun 202611:08 amRNSNet Asset Value(s)
16th Jun 202611:37 amRNSNet Asset Value(s)
15th Jun 202611:43 amRNSNet Asset Value(s)
12th Jun 202611:21 amRNSNet Asset Value(s)
11th Jun 202611:05 amRNSNet Asset Value(s)
10th Jun 202611:42 amRNSNet Asset Value(s)
9th Jun 20261:11 pmRNS-RGSK to acquire IBT portfolio company Nuvalent
9th Jun 202611:47 amRNSNet Asset Value(s)
8th Jun 202611:50 amRNSNet Asset Value(s)
5th Jun 202611:36 amRNSNet Asset Value(s)
4th Jun 202611:33 amRNSNet Asset Value(s)
3rd Jun 202611:16 amRNSNet Asset Value(s)
2nd Jun 202612:01 pmRNSNet Asset Value(s)
1st Jun 202611:48 amRNSNet Asset Value(s)
29th May 202611:33 amRNSNet Asset Value(s)
28th May 202611:37 amRNSNet Asset Value(s)
27th May 202611:26 amRNSNet Asset Value(s)
26th May 202611:55 amRNSNet Asset Value(s)
22nd May 202611:33 amRNSNet Asset Value(s)
21st May 202610:57 amRNSNet Asset Value(s)
20th May 202611:31 amRNSNet Asset Value(s)
19th May 202611:35 amRNSNet Asset Value(s)
18th May 202611:36 amRNSNet Asset Value(s)
15th May 202611:45 amRNSNet Asset Value(s)
14th May 202611:45 amRNSNet Asset Value(s)
13th May 202611:35 amRNSNet Asset Value(s)
13th May 20267:00 amRNS-RResults analysis from Kepler Trust Intelligence
12th May 202611:11 amRNSNet Asset Value(s)
12th May 20267:00 amRNSHalf-year Report
11th May 202611:50 amRNSNet Asset Value(s)
8th May 202611:50 amRNSNet Asset Value(s)
7th May 202611:50 amRNSNet Asset Value(s)
6th May 20261:24 pmRNS-RInvestor Presentation via Investor Meet Company
6th May 202611:38 amRNSNet Asset Value(s)
5th May 202611:17 amRNSNet Asset Value(s)
1st May 202611:55 amRNSNet Asset Value(s)
1st May 202611:23 amRNSTotal Voting Rights
30th Apr 202611:45 amRNSNet Asset Value(s)
29th Apr 20263:25 pmRNS-RPortfolio company KalVista acquired by Chiesi
29th Apr 202610:59 amRNSNet Asset Value(s)
28th Apr 202611:46 amRNSNet Asset Value(s)
27th Apr 202611:18 amRNSNet Asset Value(s)
24th Apr 202612:49 pmRNSNet Asset Value(s)
23rd Apr 202612:01 pmRNSNet Asset Value(s)
22nd Apr 202611:55 amRNSNet Asset Value(s)
21st Apr 202611:29 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.